SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Hera " 2,557 found 🔀 AI-powered Shuffle
STARTO ENTERTAINMENT Launches the “STARTO NEWS ARCHIVES” Newsletter Service
TOKYO--(BUSINESS WIRE)--Jun 30, 2026--
‘A political decision’: FIU law school community uneasy over new dean with Trump ties
“Law schools that can build and maintain ties with the conservative parts of the country... are poised to benefit,” the new dean wrote in a cover letter.
July 2 Vallejo/Vacaville Arts-Entertainment Source: Activities
July 2: Benicia Farmers Market, 4 p.m., Downtown Benicia at First Street. July 2: Bunco Night, Vacaville Museum Guild, 5 p.m., 213 Buck Ave. To purchase tickets online, access Vacavillemuseum.org/events/. July 2: GVRD Bite Nite: 5…
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
Plus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026 Affirms 2026 guidance on key milestones Reports positive...
Leading Colorado toward modern mental health solutions
By Sean Camacho America is facing a silent crisis. Millions of Americans are living with invisible illnesses like generalized anxiety disorder (GAD), major depressive disorder (MDD), and post-traumatic stress disorder (PTSD), which decrease quality of life and, amid limited treatment options, create a vicious cycle of endless medications and, for many people, hopeless therapies. This […]
Chatbots Are Replacing Therapists With Little Scientific Evidence Behind Them
Over 100 chatbots are marketed as mental-health-focused, but experts warn they shouldn’t take the place of therapy.
Does your small business need a boost? How to get a $5,000 grant from Miami-Dade
“Small businesses are the backbone of our local economy.”
Essentia Health-Duluth Clinic welcomes psychotherapist Jeremy Perrett
Jeremy Perrett, a licensed independent clinical social worker specializing in psychotherapy, is thrilled to join the Essentia Health-Duluth Clinic.
How a Brain Messenger Protein Drives Progression of Alzheimer’s Disease
In mice, a brain protein called Arc helps spread toxic molecules from sick brain cells to healthy ones. If therapies could be designed to target the spread, they could be a powerful tool to stop disease progression.
Students in Distress Turning to AI for Mental Health Support, Study Shows
Nearly one in five college students is turning to AI for mental health reasons, and those with severe symptoms are roughly twice as likely to do so.
Star-maker Clive Davis honored at funeral that draws Bruce Springsteen, Dionne Warwick and others
Kenny G played a mournful sax solo to kick off the funeral for music legend Clive Davis. Pop music royalty, including Bruce Springsteen, Barry Manilow, Stevie Wonder and Dionne Warwick,
KATALIN KARIKÓ
She was met with resistance, got demoted and eventually forced to leave academia – but Katalin Karikó never lost focus, doubling-down on her work to harness mRNA for new vaccines and therapies. Karikó’s Nobel Prize-awarded discovery enabled the development of effective vaccines against COVID-19, offering protection to millions of people.
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
Oversubscribed $225 million concurrent private investment in public equity ("PIPE") with available cash to the combined company at closing anticipated to fund...
A tale of two World Cup experiences: As Boston reaps economic benefits, Foxboro suffers
With the World Cup taking place in their backyard, Foxboro-area restaurateurs say they have been left in the dark and are not reaping the benefits from the economic boom seen in Boston.
Is Miami Beach getting a new marine science hub? North Beach residents hope so
Neighbors want the center to educate young people about the area’s marine ecosystems while also serving as an attraction for visitors.
Sword Health contracted to provide AI-supported physical therapy for an entire country
Portugal's National Health Service signed a deal with digital health company Sword for its AI-assisted virtual physical therapy care.
Platner Has Slight Edge Over Collins in Tight Maine Senate Race, Poll Finds
The Maine race, which both parties see as key to winning control of the Senate, is extremely close as the sprint to fall begins, a Times/Portland Press Herald/Siena poll found.
Editorial: Feds find more health care fraud
It shouldn’t be too much to ask that taxpayer-funded social service programs benefit people who actually exist.
Just hopes agent is 'busy' after World Cup impact
Elijah Just hopes his agent is "busy at the moment" as the New Zealand midfielder hinted at a possible summer exit from Motherwell after impressing at the World Cup. Just only joined Motherwell from Danish club Horsens a year ago and is under contract until next summer, with the Scottish Premiership club having an option of extending that by a further year. "The World Cup has given me added belief and also motivation to keep pushing," Just told the NZ Herald.
Life Science Reagent Market Forecast Points Higher Toward 2035, Driven by Biopharma Scale-Up and Cell Therapy Expansion
World life science reagent market forecast 2026-2035: CAGR 6-8%, index 2035=185. Bioprocessing, cell therapy, and QC drive growth. Key players: Thermo Fisher, Merck, Danaher.
Comedian Bill Maher wins Twain humor prize as the Kennedy Center navigates Trump-era upheaval
Comedian Bill Maher is being awarded the prestigious Mark Twain Prize for American Humor. The ceremony is happening at the Kennedy Center, which has been embroiled in controversy. President Donald
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
How did EBS science show reach Netflix's top 10?
For years, South Korea’s public Educational Broadcasting System has struggled to rival the massive budgets of global streaming originals and star-driven mainstr
‘Inner party turf wars’ hang over annual Florida Republican convention
Byron Donalds and state party chair Evan Power also detailed how they plan to frame Florida’s moderate Democratic candidates as progressives.
From global politics to legendary performances: 110 years of Western Herald
June 28, 2026 marks the 110th birthday of Western Herald, celebrating over a century of journalism and dedication to delivering news to campus.
Science & Medicine: Scanning the brain to improve treatment for traumatized teens
Around 20% of teens who have experienced emotional trauma don't respond to talk therapy. UT Health San Antonio is using neuroimaging to track brain changes in traumatized teens during a course of therapy to see if they can figure out why, which could lead to the development of more personalized treatments that will help more teens heal.
Pols & Politics: Why not make looser drinking laws for World Cup permanent, observers ask
Massachusetts relaxed its rules on public drinking to accommodate World Cup fans. One libertarian magazine is wondering why it isn’t permanent. Plus: Lawsuit to compel audit being considered.
Politics: Sand speaks with TH on launch of “Rob-publicans” campaign
Ahead of the unveiling of his “Rob-publicans” campaign, Democratic Iowa gubernatorial candidate Rob Sand sat down with the Telegraph Herald to discuss his stance on excess partisanship and what it
How AI is changing and challenging healthcare access
More people are consulting bots in place of physicians and therapists
How AI changing and challenging healthcare access
More people are consulting bots in place of physicians and therapists
Carlisle Cathedral, University of Cumbria secure grant to explore science and faith connections in local farming landscapes - Lutheran Alliance for Faith, Science and Technology
Carlisle Cathedral and the University of Cumbria won a £9,850 grant to explore how science and faith connect in Cumbria's farming landscapes.
TherapyGo Announces Milestone as AI-Powered Mental Health Platform Expands Access to Licensed Psychologists
BOCA RATON, Fla., June 27, 2026 (GLOBE NEWSWIRE) -- United Innovation Solutions LLC today announced a major growth milestone for TherapyGo, its ...
Scientists in Synagogues grant program to name finalists in July - Lutheran Alliance for Faith, Science and Technology
Sinai and Synapses has launched a $5,000 Scientists in Synagogues grant program promoting Judaism and science. Finalists will be named in July.
Los Alamos Faith and Science Forum launches 2026 Summer Series - Lutheran Alliance for Faith, Science and Technology
The Los Alamos Faith and Science Forum's 2026 summer season is on, offering weekly presentations on humanity’s most enduring scientific and spiritual questions.
Yankees Birthday of the Day: Eric Reyzelman
Celebrating an unheralded Yankees prospect on his 25th birthday!
New vitamin B12 therapy shows promise against deadly brain cancer
Researchers have identified a vitamin B12–based compound that can cross the blood-brain barrier and home in on glioblastoma tumors. In animal studies, the compound accumulated preferentially in tumor tissue and delivered sustained nitric oxide directly to cancer cells. It also worked synergistically with existing glioblastoma treatments, significantly enhancing their tumor-fighting effects.
Where to find free summer entertainment in Boston
Our guide to free summer music, movies, and theater.
Melissa Etheridge: 'We're going to rock your toes off'
Melissa Etheridge is a survivor. For starters, try coming out publicly as a lesbian in January 1992 at a time when entertainers didn’t do that kind of thing; surviving breast
Senators call for military healthcare program to cover autism therapy as a basic benefit
A letter to Defense Secretary Pete Hegseth follows an NBC News investigation into the military healthcare program’s restrictions on applied behavioral therapy.
These Deals on Video Games, Controllers, and Peripherals Will Disappear When Prime Day Ends Tonight
These are the best last-chance gaming deals for the last day of Prime Day: Save on top video games like Elden Ring, plus premium controllers, gaming mice, and essential peripherals.
Ann Blyth, teen star of 'Mildred Pierce,' dead at 98
Ann Blyth, an Oscar nominee at 17 as Joan Crawford’s wayward daughter in “Mildred Pierce” who later sang opposite Mario Lanza and Howard Keel in MGM musicals of the 1950s,
OHSU advances massive leap in medical science with cellular therapies
Patients are benefiting from CAR-T to treat neurodegenerative diseases, cancer, lupus and other autoimmune conditions.
Happy birthday, 2000 Year Old Man. Mel Brooks is turning 100
The 2000 Year Old Man is turning 100. Mel Brooks on Sunday will celebrate his centennial birthday. The comedian and filmmaker has been awaiting the milestone. Earlier this year, Judd
Medical breakthroughs collide with the health system
The buzziest advances — like personalized gene therapies or AI-discovered drugs — may not deliver.
Will Red Grooms' whimsical, wonderful Tennessee Fox Trot Carousel ride again?
The Tennessee State Museum in Nashville is considering how to bring a beloved whimsical carousel back to life. The Tennessee Fox Trot Carousel was the creation of Nashville-born artist Red
UT Health San Antonio researcher receives $400,000 Komen grant to study therapeutic yoga for breast cancer survivors
UT Health San Antonio researcher receives $400,000 Komen grant to study therapeutic yoga for breast cancer survivors
This autism therapy is covered by many insurers. Why does the military’s plan restrict it?
Logan Cabiao started applied behavior analysis therapy for autism when he was 2. Several years later, TRICARE, the military’s healthcare program, imposed major coverage restrictions.
Health Watch: Scientists say animal therapy helps critically ill patients, prompting new legislation
Shockwave Medical announces new studies evaluating carotid IVL platform
Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease.
UT Health San Antonio researcher receives $400,000 Komen grant to study therapeutic yoga for breast cancer survivors
Amelie G. Ramirez, DrPH, MPH, to work with Hispanics in South Texas Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Cliff Despres SAN ANTONIO, June 25, 2026 – Amelie G. Ramirez, DrPH, MPH, a cancer researcher at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, is […]
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
PsychPlus Acquires Koa Health
Houston, Texas-based psychiatry practice PsychPlus has acquired Koa Health, a London-based digital therapeutic and B2B-focused digital mental health
PsychPlus Acquires Koa Health
Houston, Texas-based psychiatry practice PsychPlus has acquired Koa Health, a London-based digital therapeutic and B2B-focused digital mental health
13 things to do this weekend around the Seattle area
From the Seattle Pride Parade to new art gallery exhibitions, here are the latest local things to do around the Seattle area.
12 arrested in South Florida in nationwide investigation into $6.5B health care fraud
Investigators say Medicaid and Medicare thieves in South Florida bilked taxpayers for $27 million for everything from fake therapy to medical equipment patients never received. Officials seized the stolen taxpayer money from Key West to Fort Pierce.
Another look at carrots and eyesight; how to get more fiber; why mosquitoes bite some people and not others; plus other stories with Vanderbilt Health sources
AARP reporter Stacey Colino interviewed Milam Brantley, MD, Associate Professor of Ophthalmology and Visual Sciences, in 2020 for a story about whether eating carrots can improve vision. Sacramento Bee reporter Samantha Agate has now used Brantley’s comments in an AI-curated story created by content specialists on the same topic that has been picked up by MSN and others. Prevention magazine interviewed Heidi Silver, RD, PhD, Founding Director of the Vanderbilt Diet, Body Composition, and Human Metabolism Core, for a story about the importance of fiber and how people can get more of it in their diet. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: Women’s Health (tick bites and alpha-gal syndrome); The Washington Post (tetanus); and Healthline (why mosquitoes prefer to bite some people and leave others alone). A visit to Monroe Carell Jr. Children’s Hospital at Vanderbilt by some Banana Ball baseball players was covered by The Tennessean and WZTV Fox 17 News, and The Tennessean’s story was also picked up by Yahoo! Sports. Clarksville Now published a story written by the Montgomery County Economic Development Team, whointerviewed Bradley Stancombe, MD, professor of Clinical Pediatrics, Vanderbilt Neonatology, about the new energy of Vanderbilt Clarksville Hospital and how the facility is recruiting physicians. Healio Allergy/Asthma group editorial director Richard Gawel interviewed Mark Rolfsen, MD, Clinical Fellow in the Division of Allergy, Pulmonary and Critical Care Medicine, for a story about his presentation at the American Thoracic Society meeting on metal health outcomes following ICU discharge. Nashville Scene reporter Hannah Herner interviewed James Crowe, MD, Director of the Vanderbilt Center for Antibody Therapeutics, for a story about his efforts to prepare for the next pandemic by isolating antibodies that can neutralize dangerous viruses. Medscape reporter Kathleen Doheny interviewed Neesha Choma, Associate Chief of Staff of Vanderbilt University Hospital, for a story about how hospitals can reduce readmissions.
Psychedelic Science 2027 Speaker Submission Invites the Field to Bridge Promise and Practice
Psychedelic Science 2027 (PS27) convenes May 3–7, 2027, at the Colorado Convention Center in Denver under the theme “Bridging Promise & Practice”PS27’s speaker submission is now open through Friday, September 18, with no planned extensionsPS27 welcomes proposals across science, therapy, policy, culture, industry, the humanities, spirituality, connected movements, and the wisdom traditions that have carried this work for generations DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary
Immigrant-led residential care businesses in Maine launch new coalition
The group consists of 30 agencies who provide Medicare services to Mainers with intellectual disabilities and autism.
FDA-approved drug may finally help immunotherapy defeat rare liver cancer
Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those T cells to attack the cancer, significantly improving the effectiveness of immunotherapy in tumor samples.
Who's No. 1 in Morris/Sussex high school sports?
The Daily Record and New Jersey Herald totaled up each high school's 2025-26 success to determine the Top 10 athletic programs.
The Herald's weekly entertainment picks
Looking to be entertained from Thursday, June 25, through Wednesday, July 1? Check out the Skagit Valley Herald’s weekly recommendations.
4 new mysteries and thrillers perfect for long summer days
This month's lineup of new mysteries and thrillers offers plenty of suspicious ongoings, dark secrets and deliciously twisty plots.
Exploring Heat’s search for shooters and what makes sense with roster, finances
A look at the Heat’s search for shooters to put around Giannis Antetokounmpo and Bam Adebayo
How wellness and longevity trends are reshaping American real estate
Health-obsessed homebuyers are splurging on cold plunges, saunas, and cryotherapy chambers. Real estate's biggest flex isn't just for the uber-rich.
The science of justice
The newly established Center for Forensic Sciences in Georgia Southern University’s College of Science and Mathematics will make the university’s experts available to an expanded range of law enforcement agencies across the Southeast.
First patient receives neural stem cell therapy in groundbreaking UCI Health Huntington's disease clinical trial
World’s first neural stem cell phase 1b/2a clinical trial for condition leverages innovative technology
Massachusetts man among 455 charged in nationwide crackdown on health care fraud
A Massachusetts man is among 455 people charged in a nationwide crackdown on health care fraud, with the Stoughton man allegedly carrying out an over $5 million Medicare fraud scheme.
Lexington-Fayette Health Department shuts down mall restaurant
The health department closed down a restaurant in the Fayette Mall after repeated failed inspections according to the Lexington Herald-Leader.
Kenya’s health minister orders suspension of construction on a US-backed Ebola facility
Locals have held a series of protests in which three people have died.
Renowned Life Science Leader Dr. Gino Martini Joins KIFFIK Biomedical as Chief Scientific Officer
Dr. Martini brings extensive industry, government, and academic expertise to KIFFIK Biomedical, strengthening translational science capabilities as the company advances its K-EXP™ platform and expands access to interstitial fluid (ISF)
No. 1 Mistake People Make When Buying Walking Shoes That Harms Foot Health
In TODAY.com’s Expert Tip of the Day, a physical therapist reveals a common mistake people make when choosing walking shoes and how to fix it for better foot health.
Biz Buzz: Health and wellness business opens event space in Dubuque
Biz Buzz shares business tidbits from across the tri-states. In addition to this update from Dubuque, other developments will appear in Wednesday’s edition.
Clive Davis, music industry starmaker, has died at 94
Clive Davis, who rose from a job as a record company lawyer to become one of the music industry’s most powerful figures, has died at the age of 94. Davis
Erika Alexander compares 'Reggie Dinkins' costar Daniel Radcliffe to 'a therapy dog'
'The Fall and Rise of Reggie Dinkins' star Daniel Radcliffe is a calming presence on set, but will also jump to protect Tracy Morgan from being bit by a dog.
Breaking Business News: AbbVie To Acquire Apogee Therapeutics
AbbVie is set to acquire Apogee Therapeutics and its pipeline of multiple clinical-stage candidates in development across inflammatory and immunological diseases, including its lead asset, zumilokibart (APG777), a subcutaneous half-life extended monoclonal antibody targeting interleukin (IL)-13 in atopic dermatitis (AD). Under the terms of the transaction, AbbVie will acquire all outstanding shares of Apogee for $135.11 per share in cash. […]
Mental health counselor charged with ethics violation
The Iowa Board of Behavioral Health Professionals has disclosed disciplinary charges it filed last summer against a mental health counselor.
There's 'menopause legislation' in the works. What does that mean?
More than half of the states have introduced or passed menopause bills including requiring insurance companies to cover hormone therapy.
New York Giants' Unheralded Weapon is Already Surprising Everyone
This New York Giants wide receiver has been a big surprise during the team's offseason program.
What Science Knows About Grief
After my husband’s death, I had never been more pliable, tender, open, or raw. It was then that I tried E.M.D.R. therapy.
CVS Pharmacy® expands GLP-1 support to lower costs, improve access, and help patients stay on therapy
New $50 monthly copay for eligible Medicare patients, one-on-one pharmacist guidance, and over-the-counter products to help manage common side effects available to support patients
Signs of Thaw in the Bering Sea
Drifting sea ice fragments near Alaska’s Saint Lawrence and Nunivak islands and colorful water around the Yukon Delta heralded the approach of the summer solstice.
What men should know about the US government's latest move on testosterone therapy
The U.S. Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies for men after reviewing new data and evidence on their safety and benefits.
What men should know about the US government's latest move on testosterone therapy
The U.S. Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies for men after reviewing new data and evidence on their safety and benefits.
DCCA expands pathway for mental health professionals ahead of July 1 launch
The Department of Commerce and Consumer Affairs is preparing for the July 1 implementation of Act 93, which creates new provisional licenses for associate psychologists, associate marriage and family therapists, and associate mental health counselors.
As Giannis wait drags on, a look at bigs who could be available for Heat at No. 13 in 2026 Draft
If no Giannis Antetokounmpo, will the Heat use its first-round pick in the draft to add size to its roster?
Nicole Kidman looks wonderfully witchy in ‘Practical Magic 2’ preview
The film, starring Kidman and Sandra Bullock, whizzes into theaters — presumably on broomsticks — Sept. 11.
The Science Behind Why Certain People Instantly Make You Feel Calmer
Being with others can sometimes make you feel calmer. Therapists explain the science behind co-regulation and how to cultivate it in your relationships.
Pols & Politics: Boston Mayor Wu joins Scottish statue traffic cone prank: ‘A sense of joy everywhere’
Boston Mayor Michelle Wu admitted to joining in on a traditional Tartan Army prank by placing a traffic cone on a statue outside City Hall. Plus: US Attorney Leah Foley’s special necklace.
Retailers are making billions selling ads, not just products
For decades, retailers made money the old-fashioned way: Buying merchandise and selling it for more than they paid.
Galena-area zipline, adventure park business takes its guests through the trees
GALENA, Ill. — Visitors to a rural Jo Daviess County business can zip through dense woodlands, conquer treetop obstacles and explore treehouses.
Le'Stuff Antique Mall Celebrates 25 Years In Business ~ The Greatest Treasure Is The Owners
Le'Stuff Antique Mall Celebrates 25 Years in Hillsboro, Oregon. The amazing store is something special and it's owners are even more so.
Politics: Cook Political Report shifts IA-02 race to “Lean R”
Just three weeks on from Iowa’s primary election, the nonpartisan Cook Political Report has shifted the race for Iowa’s 2nd Congressional District from “Likely Republican” to a tighter “Lean Republican,”
What men should know about the US government’s latest move on testosterone therapy
The US Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies for men after reviewing new data and evidence on their safety and benefits. These updates could pave the way for easier access to testosterone replacement therapy.
'Leviticus' finds hope in the horrors of gay conversion therapy
Spoiler alert! We're discussing major details about the ending of “Leviticus” (in theaters now). Stop reading if you haven’t seen the film and don’t want to know.
This week in politics: How Schuylkill County’s legislators voted
The PA House of Representatives was in session this past week and passed 16 bills. Let’s take a look at how Schuylkill County’s legislators voted on notable pieces of legislation. PA General Assembly HB 2084, PA Promise – Improving Co…
Battenfeld: Michelle Wu’s unlikely nemesis — ex-con Dianne Wilkerson
Wilkerson, who ran for her old seat in 2022, is trying to mobilize Boston’s Black community in what could be an attempt to put together a powerful voting bloc in a future election. So she is a threat to Wu and has the potential to embarrass…
Democrats seeking Wisconsin congressional seats discuss key issues in Platteville
PLATTEVILLE, Wis. — More than 50 people gathered Thursday evening in Platteville to hear from the Democratic candidates for Wisconsin’s 3rd Congressional District, Emily Berge and Rebecca Cooke.
What is the Pickaway County Fair entertainment?
The Pickaway County Fair may be known best for its livestock judging, but there is so much more! The entertainment aspects to the fair are worth looking into.
Seattle’s Woodside/Braseth Gallery celebrates 65 years
Seattle's Woodside/Braseth Gallery is now one of the oldest continuously run galleries in the United States.
San Diego's wellness industry business is booming
From cold plunges to hormone therapy, new concepts are expanding across the county.